Multi-drug precision medicine cancer trial begins
Patients on the trial will have one of the particular genetic mutations among rare cancers
Read More
Author: John Pinching
Study brings personalised immunotherapy prescriptions closer
Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable
Read More
Medicines for Malaria Venture and Novartis move to phase 3 trial
Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments
Read More
Takeda findings may minimise haemophilia treatment side effects
Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients
Read More
Turbine boosts AI platform to deliver cancer treatments
€20m financing will focus on treatment pathways, new partnerships and team expansion
Read More- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
